3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Leukemia, Myeloid, Acute
76
Leukemia
43
Precursor Cell Lymphoblastic Leukemia-Lymphoma
16
Leukemia, Myelomonocytic, Acute
16
Leukemia, Monocytic, Acute
16
Congenital Abnormalities
16
Leukemia, Megakaryoblastic, Acute
14
Leukemia, Erythroblastic, Acute
14
Myelodysplastic Syndromes
11
Leukemia, Promyelocytic, Acute
8
Leukemia, Myelomonocytic, Chronic
8
Anemia, Refractory, with Excess of Blasts
8
Recurrence
6
Myeloproliferative Disorders
5
Leukemia, Eosinophilic, Acute
5
Leukemia, Basophilic, Acute
4
Lymphoma
3
Leukemia, Myeloid, Chronic-Phase
3
Blast Crisis
3
Neutropenia
2
Neoplasms
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large-Cell, Immunoblastic
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Carcinoma, Hepatocellular
2
Thrombocythemia, Essential
1
Sarcoma, Synovial
1
Interventions
Doxorubicin
80
Ifosfamide
54
Radiotherapy
43
Filgrastim
41
Gemcitabine
38
Cyclophosphamide
34
Etoposide
26
Vincristine
24
Cisplatin
24
Docetaxel
23
pazopanib
21
Trabectedin
19
Carboplatin
17
pembrolizumab
15
Peripheral Blood Stem Cell Transplantation
14
eribulin
12
Mesna
12
Melphalan
12
Sorafenib
11
Sirolimus
11
Irinotecan
11
Granulocyte Colony-Stimulating Factor
11
Bevacizumab
11
Topotecan
10
Paclitaxel
10
Imatinib Mesylate
10
Chemotherapy, Adjuvant
10
pegfilgrastim
9
Temozolomide
9
Surgical Procedures, Operative
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Sarcoma
×
Idarubicin
×
Clear all
NCT00876031
2022-11-08
CWS-2007-HR
University Hospital Tuebingen
Phase 3
Completed
195 enrolled